We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Lung Ultrasound Bests X-Rays for COVID-19 Diagnosis

By MedImaging International staff writers
Posted on 16 Nov 2020
Print article
Lung ultrasound (LUS) is more reliable than an anterior-posterior chest x-ray (CXR) for detecting COVID-19, according to a new study.

Researchers at Temple University Hospital (Philadelphia, PA, USA) conducted a prospective study over a two-week period in April 2020, during which a surge in COVID-19 cases was observed. In all, 143 adult patients with signs and symptoms of COVID-19 were enrolled as they came into the emergency department (ED). The symptoms included a temperature of 38° Celsius or higher, a heart rate of 100 bpm or higher, a respiratory rate of 16 rpm or greater, oxygen saturation (SpO2) less than 94%, and a combination of cough, dyspnea, myalgia, malaise, ageusia, and anosmia.

The researchers compared the diagnostic performance of LUS performed with a portable hand-held device to CXR. For a definitive diagnosis, COVID-19 infection was confirmed with non-contrast-enhanced computed tomography (NCCT), a radiographic diagnostic standard that delivers near-perfect sensitivity of atypical pneumonia. The results revealed that in the 70 patients with both positive LUS and CXR test results, 58 had a positive NCCT. In the 42 patients with a positive LUS and a negative CXR, only 23 had a positive NCCT.

In the six patients who had a positive CXR and a negative LUS, there were no positive NCCTs, indicating lung ultrasound was the more reliable indicator. In all, they found that LUS had a sensitivity of 97.6% compared with CXR at 69.9%. Specificity was 33.3% for LUS and 44.4% for CXR. A total of 81 patients tested positive for COVID-19 with NCCT, for a disease prevalence of 75%. The study was presented at the American College of Emergency Physicians (ACEP), held online during October 2020.

“We continue to be confronted with a diagnostic challenge; patients often have vague non-specific multi-system presentations,” said lead author and study presenter Kendra Mendez, MD. “We found that lung ultrasound sensitivity outperforms chest x-ray for diagnosis of COVID-19 pneumonia. Lung ultrasound can be an especially valuable triage screening modality in resource-limited settings.”

While NCCT has excellent ability to detect COVID-19, the modality can't be used at patients' bedsides and it puts additional medical staff at risk for virus exposure. As a result, doctors all over the world are turning to lung ultrasound as an alternative imaging modality.

Related Links:
Temple University Hospital

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Calibration Electrometer
PC Electrometer
Advanced Cardiac MRI Analysis Software
3Di Cardiac MR
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.